Senti Biosciences, Inc (SNTI) insider trading
Every open-market stock purchase and sale by Senti Biosciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Bayer Healthcare LLC (10% owner), $7.7M, 22 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent SNTI insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 9, 2026 | Kanya Rajangam (Officer) | Sold (not open market) | — |
| Mar 9, 2026 | Timothy K Lu (CEO) | Sold (not open market) | — |
| Feb 2, 2026 | Timothy K Lu (CEO) | Sold (not open market) | — |
| Feb 2, 2026 | Kanya Rajangam (Officer) | Sold (not open market) | — |
Who's trading SNTI
- Kanya Rajangam, Officer: other filings, last Mar 9, 2026
- Timothy K Lu, CEO: other filings, last Mar 9, 2026
Get free alerts when an insider at Senti Biosciences, Inc files a new trade →